These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 19720104)

  • 1. Peptide corresponding to the C terminus of tissue factor pathway inhibitor inhibits mesangial cell proliferation and activation in vivo.
    Liang W; Cheng J; Liu R; Wang JP; Mu JG; Wang QH; Wang HJ; Ma D
    Peptides; 2009 Dec; 30(12):2330-6. PubMed ID: 19720104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant tissue factor pathway inhibitor induces apoptosis in cultured rat mesangial cells via its Kunitz-3 domain and C-terminal through inhibiting PI3-kinase/Akt pathway.
    Lin YF; Zhang N; Guo HS; Kong DS; Jiang T; Liang W; Zhao ZH; Tang QQ; Ma D
    Apoptosis; 2007 Dec; 12(12):2163-73. PubMed ID: 17885802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of decorin induces apoptosis and cell growth arrest in cultured rat mesangial cells in vitro.
    Wu H; Wang S; Xue A; Liu Y; Liu Y; Wang H; Chen Q; Guo M; Zhang Z
    Nephrology (Carlton); 2008 Oct; 13(7):607-15. PubMed ID: 18518935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tissue factor pathway inhibitor on apoptosis of rat mesangial cells and Fas and bcl-2 expression].
    Lin YF; Ma D; Liang W; Jiang T; Zhao ZH; Zhang N
    Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):754-9. PubMed ID: 19094710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated gene transfer of tissue factor pathway inhibitor induces apoptosis in vascular smooth muscle cells.
    Fu Y; Zhang Z; Zhang G; Liu Y; Cao Y; Yu J; Hu J; Yin X
    Apoptosis; 2008 May; 13(5):634-40. PubMed ID: 18368493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characterization of tissue factor pathway inhibitor following degradation by matrix metalloproteinase-8.
    Cunningham AC; Hasty KA; Enghild JJ; Mast AE
    Biochem J; 2002 Oct; 367(Pt 2):451-8. PubMed ID: 12117418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor pathway inhibitor production by human mesangial cells in culture.
    Yamabe H; Osawa H; Inuma H; Kaizuka M; Tamura N; Tsunoda S; Fujita Y; Shirato K; Onodera K
    Thromb Haemost; 1996 Aug; 76(2):215-9. PubMed ID: 8865534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor.
    Mukherjee M; Kakkar VV
    Thromb Haemost; 1999 Dec; 82(6):1648-51. PubMed ID: 10613650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits.
    Erlich JH; Apostolopoulos J; Wun TC; Kretzmer KK; Holdsworth SR; Tipping PG
    J Clin Invest; 1996 Jul; 98(2):325-35. PubMed ID: 8755641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning, expression, and characterization of mouse tissue factor pathway inhibitor (TFPI).
    Chang JY; Monroe DM; Oliver JA; Liles DK; Roberts HR
    Thromb Haemost; 1998 Feb; 79(2):306-9. PubMed ID: 9493581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that the C-terminus of tissue factor pathway inhibitor (TFPI) is essential for its in vitro and in vivo interaction with lipoproteins.
    Valentin S; Nordfang O; Bregengård C; Wildgoose P
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):713-20. PubMed ID: 8292720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation.
    Dorado F; Velasco S; Esparís-Ogando A; Pericacho M; Pandiella A; Silva J; López-Novoa JM; Rodríguez-Barbero A
    Nephrol Dial Transplant; 2008 Nov; 23(11):3403-11. PubMed ID: 18567890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin suppresses cell proliferation and fibronectin expression via p38MAPK pathway in rat mesangial cells cultured under high glucose.
    Li X; Liu W; Wang Q; Liu P; Deng Y; Lan T; Zhang X; Qiu B; Ning H; Huang H
    Mol Cell Endocrinol; 2009 Aug; 307(1-2):157-62. PubMed ID: 19524136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
    Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
    J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue factor pathway inhibitor; its structure, function and clinical significance.
    Kato H
    Pol J Pharmacol; 1996; 48(1):67-72. PubMed ID: 9112630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression.
    Gu B; Ding Q; Xia G; Fang Z
    Oncol Rep; 2009 Mar; 21(3):635-40. PubMed ID: 19212621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of plasma tissue factor pathway inhibitor.
    Broze GJ; Lange GW; Duffin KL; MacPhail L
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):551-9. PubMed ID: 7841311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding.
    Piro O; Broze GJ
    Circulation; 2004 Dec; 110(23):3567-72. PubMed ID: 15557366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.